Adjuvant inhibition of the epidermal growth factor receptor after fractionated irradiation of FaDu human squamous cell carcinoma
- 1 July 2004
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 72 (1) , 95-101
- https://doi.org/10.1016/j.radonc.2004.05.003
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Combined-Modality Treatment of Solid Tumors Using Radiotherapy and Molecular Targeted AgentsJournal of Clinical Oncology, 2003
- Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of CancerJournal of Clinical Oncology, 2003
- EGFR blockade with ZD1839 (“Iressa”) potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Splicing Mutations in TP53 in Human Squamous Cell Carcinoma Lines Influence Immunohistochemical DetectionJournal of Histochemistry & Cytochemistry, 2002
- The EGF receptor family as targets for cancer therapyOncogene, 2000
- Combined Modality Therapy of A431 Human Epidermoid Cancer Using Anti-EGFr Antibody C225 and RadiationCancer Biotherapy & Radiopharmaceuticals, 1999
- Impact of preirradiation of the tumour bed on cell production rate and cell loss of human FaDu squamous cell carcinoma growing in nude miceInternational Journal of Radiation Biology, 1999
- Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylationOncogene, 1997
- Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitroInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Stromal radiosensitivity: influence of tumour type on the Tumour Bed Effect assayThe British Journal of Radiology, 1985